TO RECEIVE THE ANNUAL REPORT AND ACCOUNTS OF THE COMPANY FOR THE YEAR ENDED 31 MARCH 2025 TOGETHER WITH THE DIRECTORS REPORTS AND AUDITORS REPORT ON THOSE ACCOUNTS
TO ACCEPT THE REMUNERATION COMMITTEE REPORT FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025, AS SET OUT IN THE COMPANYS ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 MARCH 2025
TO ACCEPT THE DIRECTORS REMUNERATION POLICY, AS SET OUT IN THE COMPANYS ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 MARCH 2025
TO RE-APPOINT JASON HOLT AS A DIRECTOR OF THE COMPANY
TO RE-APPOINT DR MICHAEL HUDSON AS A DIRECTOR OF THE COMPANY
TO RE-APPOINT PROFESSOR SIR CHRISTOPHER EVANS AS A DIRECTOR OF THE COMPANY
TO RE-APPOINT PROFESSOR TREVOR JONES AS A DIRECTOR OF THE COMPANY
TO APPOINT MARTIN WALTON AS A DIRECTOR OF THE COMPANY
TO RE-APPOINT PKF LITTLEJOHN LLP AS AUDITOR OF THE COMPANY
TO AUTHORISE THE DIRECTORS TO DETERMINE THE FEES PAYABLE TO THE AUDITOR
TO APPROVE THE EDX MEDICAL GROUP PLC NON-ENTERPRISE MANAGEMENT INCENTIVE PLAN
TO APPROVE THE EDX MEDICAL GROUP PLC ENTERPRISE MANAGEMENT INCENTIVE PLAN
TO AUTHORISE THE DIRECTORS TO ALLOT SHARES IN THE COMPANY
TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS GENERALLY
TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS PURSUANT TO AN ACQUISITION OR OTHER CAPITAL INVESTMENT
TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES